ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI, 2013. The global distribution and burden of dengue. Nature 496: 504–507.
-
2.
World Health Organization (WHO), 2009. Dengue and dengue hemorrhagic fever. Available at: http://www.who.int/mediacentre/factsheets/fs117/en/. Accessed December 1, 2013.
-
3.
Simmons CP, Farrar JJ, Chau NV, Wills B, 2012. Dengue. N Engl J Med 366: 1423–1432.
-
4.
Kularatne SA, 2005. Survey on the management of dengue infection in Sri Lanka: opinions of physicians and pediatricians. Southeast Asian J Trop Med Public Health 36: 1198–1200.
-
5.
Teoh SC, Chee CK, Laude A, Goh KY, Barkham T, Ang BS, 2010. Optical coherence tomography patterns as predictors of visual outcome in dengue-related maculopathy. Retina 30: 390–398.
-
6.
Obeyesekere I, Hermon Y, 1973. Arbovirus heart disease: myocarditis and cardiomyopathy following dengue and chikungunya fever—a follow-up study. Am Heart J 85: 186–194.
-
7.
Solomon T, Dung NM, Vaughn DW, Kneen R, Thao LT, Raengsakulrach B, Loan HT, Day NP, Farrar J, Myint KS, Warrell MJ, James WS, Nisalak A, White NJ, 2000. Neurological manifestations of dengue infection. Lancet 355: 1053–1059.
-
8.
Wang LY, Chang WY, Lu SN, Chen TP, 1990. Sequential changes of serum transaminase and abdominal sonography in patients with suspected dengue fever. Kaohsiung J Med Sci 6: 483–489.
-
9.
Gonzales D, Martinez R, Castro O, Serrano T, Portela D, Vazquez S, Kouri G, Guzman MG, 2005. Evaluation of some clinical, humoral and imagenological parameters in patients of dengue hemorrhagic fever six months after acute illness. Dengue Bull 29: 79–84.
-
10.
Seet RC, Quek AM, Lim EC, 2007. Post-infectious fatigue syndrome in dengue infection. J Clin Virol 38: 1–6.
-
11.
Caballero M, Brown A, Torres E, 1986. Resultado del seguimiento a un grupo de pacientes graves de dengue hemorragico. Rev Cubana Enferm 2: 68–77.
-
12.
del Valle Diaz S, Martinez M, Saent-Felix F, 2001. Hepatitis reactiva por virus del dengue hemorragico. Rev Cubana Med Trop 53: 28–31.
-
13.
Garcia G, Gonzalez N, Perez AB, Sierra B, Aguirre E, Rizo D, Izquierdo A, Sanchez L, Diaz D, Lezcay M, Pacheco B, Hirayama K, Guzman MG, 2011. Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders. Int J Infect Dis 15: e38–e43.
-
14.
Teixeira L de A, Lopes JS, Martins AG, Campos FA, Miranzi S de S, Nascentes GA, 2010. Persistence of dengue symptoms in patients in Uberaba, Minas Gerais State, Brazil. Cad Saude Publica 26: 624–630.
-
15.
Low JG, Ooi EE, Tolfvenstam T, Leo YS, Hibberd ML, Ng LC, Lai YL, Yap GS, Li CS, Vasudevan SG, Ong A, 2006. Early dengue infection and outcome study (EDEN) - study design and preliminary findings. Ann Acad Med Singapore 35: 783–789.
-
16.
Halsey ES, Marks MA, Gotuzzo E, Fiestas V, Suarez L, Vargas J, Aguayo N, Madrid C, Vimos C, Kochel TJ, Laguna-Torres VA, 2012. Correlation of serotype-specific dengue virus infection with clinical manifestations. PLoS Negl Trop Dis 6: e1638.
-
17.
Forshey BM, Guevara C, Laguna-Torres VA, Cespedes M, Vargas J, Gianella A, Vallejo E, Madrid C, Aguayo N, Gotuzzo E, Suarez V, Morales AM, Beingolea L, Reyes N, Perez J, Negrete M, Rocha C, Morrison AC, Russell KL, Blair PJ, Olson JG, Kochel TJ, 2010. Arboviral etiologies of acute febrile illnesses in Western South America, 2000–2007. PLoS Negl Trop Dis 4: e787.
-
18.
Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV, 1992. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30: 545–551.
-
19.
Vaughn DW, Nisalak A, Solomon T, Kalayanarooj S, Nguyen MD, Kneen R, Cuzzubbo A, Devine PL, 1999. Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am J Trop Med Hyg 60: 693–698.
-
20.
PAHO. Dengue: statistics and maps. Available at: http://www.paho.org/HQ/index.php?option=com_content&view=article&id=719%3Anumber-of-reported-cases-of-dengue-and-dengue-hemorrhagic-fever-dhf%2A-in-the-americas%2C-by-country&catid=1221%3Ahsd0103b-dengue-statistics-a-maps&Itemid=2481&lang=en. Accessed December 1, 2013.
-
21.
Wilder-Smith A, Schwartz E, 2005. Dengue in travelers. N Engl J Med 353: 924–932.
-
22.
Cobra C, Rigau-Perez JG, Kuno G, Vorndam V, 1995. Symptoms of dengue fever in relation to host immunologic response and virus serotype, Puerto Rico, 1990–1991. Am J Epidemiol 142: 1204–1211.
-
23.
Mickiene A, Laiskonis A, Gunther G, Vene S, Lundkvist A, Lindquist L, 2002. Tickborne encephalitis in an area of high endemicity in Lithuania: disease severity and long-term prognosis. Clin Infect Dis 35: 650–658.
-
24.
Loeb M, Hanna S, Nicolle L, Eyles J, Elliott S, Rathbone M, Drebot M, Neupane B, Fearon M, Mahony J, 2008. Prognosis after West Nile virus infection. Ann Intern Med 149: 232–241.
-
25.
de Andrade DC, Jean S, Clavelou P, Dallel R, Bouhassira D, 2010. Chronic pain associated with the chikungunya fever: long lasting burden of an acute illness. BMC Infect Dis 10: 31.
-
26.
Low JG, Ong A, Tan LK, Chaterji S, Chow A, Lim WY, Lee KW, Chua R, Chua CR, Tan SW, Cheung YB, Hibberd ML, Vasudevan SG, Ng LC, Leo YS, Ooi EE, 2011. The early clinical features of dengue in adults: challenges for early clinical diagnosis. PLoS Negl Trop Dis 5: e1191.
-
27.
Wang CC, Lee IK, Su MC, Lin HI, Huang YC, Liu SF, Wu CC, Lin MC, 2009. Differences in clinical and laboratory characteristics and disease severity between children and adults with dengue virus infection in Taiwan, 2002. Trans R Soc Trop Med Hyg 103: 871–877.
-
28.
Vijayakumar KP, Nair Anish TS, George B, Lawrence T, Muthukkutty SC, Ramachandran R, 2011. Clinical profile of chikungunya patients during the epidemic of 2007 in Kerala, India. J Glob Infect Dis 3: 221–226.
-
29.
Berner YN, Lang R, Chowers MY, 2002. Outcome of West Nile fever in older adults. J Am Geriatr Soc 50: 1844–1846.
-
30.
Fried JR, Gibbons RV, Kalayanarooj S, Thomas SJ, Srikiatkhachorn A, Yoon IK, Jarman RG, Green S, Rothman AL, Cummings DA, 2010. Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl Trop Dis 4: e617.
-
31.
Chan KS, Chang JS, Chang K, Lin CC, Huang JH, Lin WR, Chen TC, Hsieh HC, Lin SH, Lin JC, Lu PL, Chen YH, Lin CY, Tsai JJ, 2009. Effect of serotypes on clinical manifestations of dengue fever in adults. J Microbiol Immunol Infect 42: 471–478.
-
32.
OhAinle M, Balmaseda A, Macalalad AR, Tellez Y, Zody MC, Saborio S, Nunez A, Lennon NJ, Birren BW, Gordon A, Henn MR, Harris E, 2011. Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Sci Transl Med 3: 114–128.
-
33.
Krishnamoorthy K, Harichandrakumar KT, Krishna Kumari A, Das LK, 2009. Burden of chikungunya in India: estimates of disability adjusted life years (DALY) lost in 2006 epidemic. J Vector Borne Dis 46: 26–35.
-
34.
Proll S, Dobler G, Pfeffer M, Jelinek T, Nothdurft HD, Loscher T, 1999. Persistent arthralgias in Ross-River-Virus disease after travel to the South Pacific. Dtsch Med Wochenschr 124: 759–762.
-
35.
Halsey ES, Siles C, Guevara C, Vilcarromero S, Jhonston EJ, Ramal C, Aguilar PV, Ampuero JS, 2013. Mayaro virus infection, Amazon basin region, Peru, 2010–2013. Emerg Infect Dis 19: 1839–1842.
-
36.
Dupuis-Maguiraga L, Noret M, Brun S, Le Grand R, Gras G, Roques P, 2012. Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis 6: e1446.
-
37.
Solomon T, 2004. Flavivirus encephalitis. N Engl J Med 351: 370–378.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1748 | 1522 | 29 |
| Full Text Views | 443 | 14 | 0 |
| PDF Downloads | 168 | 16 | 0 |
Occurrence and Correlates of Symptom Persistence Following Acute Dengue Fever in Peru
Eric S. Halsey
Eric S. Halsey
Virology Department, United States Naval Medical Research Unit No. 6, Lima and Iquitos, Peru; Dirección Regional de Salud de Piura, Ministerio de Salud, Piura, Peru; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
Search for other papers by Eric S. Halsey in
Current site
Google Scholar
PubMed
Search for other papers by Eric S. Halsey in
Current site
Google Scholar
PubMed
Maya Williams
Maya Williams
Virology Department, United States Naval Medical Research Unit No. 6, Lima and Iquitos, Peru; Dirección Regional de Salud de Piura, Ministerio de Salud, Piura, Peru; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
Search for other papers by Maya Williams in
Current site
Google Scholar
PubMed
Search for other papers by Maya Williams in
Current site
Google Scholar
PubMed
V. Alberto Laguna-Torres
V. Alberto Laguna-Torres
Virology Department, United States Naval Medical Research Unit No. 6, Lima and Iquitos, Peru; Dirección Regional de Salud de Piura, Ministerio de Salud, Piura, Peru; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
Search for other papers by V. Alberto Laguna-Torres in
Current site
Google Scholar
PubMed
Search for other papers by V. Alberto Laguna-Torres in
Current site
Google Scholar
PubMed
Stalin Vilcarromero
Stalin Vilcarromero
Virology Department, United States Naval Medical Research Unit No. 6, Lima and Iquitos, Peru; Dirección Regional de Salud de Piura, Ministerio de Salud, Piura, Peru; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
Search for other papers by Stalin Vilcarromero in
Current site
Google Scholar
PubMed
Search for other papers by Stalin Vilcarromero in
Current site
Google Scholar
PubMed
Victor Ocaña
Victor Ocaña
Virology Department, United States Naval Medical Research Unit No. 6, Lima and Iquitos, Peru; Dirección Regional de Salud de Piura, Ministerio de Salud, Piura, Peru; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
Search for other papers by Victor Ocaña in
Current site
Google Scholar
PubMed
Search for other papers by Victor Ocaña in
Current site
Google Scholar
PubMed
Tadeusz J. Kochel
Tadeusz J. Kochel
Virology Department, United States Naval Medical Research Unit No. 6, Lima and Iquitos, Peru; Dirección Regional de Salud de Piura, Ministerio de Salud, Piura, Peru; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
Search for other papers by Tadeusz J. Kochel in
Current site
Google Scholar
PubMed
Search for other papers by Tadeusz J. Kochel in
Current site
Google Scholar
PubMed
Morgan A. Marks
Morgan A. Marks
Virology Department, United States Naval Medical Research Unit No. 6, Lima and Iquitos, Peru; Dirección Regional de Salud de Piura, Ministerio de Salud, Piura, Peru; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
Search for other papers by Morgan A. Marks in
Current site
Google Scholar
PubMed
Search for other papers by Morgan A. Marks in
Current site
Google Scholar
PubMed
Dengue virus (DENV) infection causes an acute febrile illness generally considered to result in either complete recovery or death. Some reviews describe persistent symptoms after the febrile phase, although empirical data supporting this phenomenon is scarce. We evaluated symptom persistence in acute febrile DENV-infected and DENV-negative (controls) individuals from Peru. Self-reported solicited symptoms were evaluated at an acute and a follow-up visit, occurring 10–60 days after symptom onset. Rate of persistence of at least one symptom was 7.7% and 10.5% for DENV infected and control subjects, respectively (P < 0.01). The DENV-infected individuals had lower rates of persistent respiratory symptoms, gastrointestinal symptoms, headache, and fatigue, but higher rates of persistent rash compared with controls. Older age and female gender were positively associated with symptom persistence. As dengue cases continue to increase annually, even a relatively low frequency of persistent symptoms may represent a considerable worldwide morbidity burden.
Author Notes
Financial support: This work was supported by the Armed Forces Health Surveillance Center Global Emerging Infections Systems Research Program [847705.82000.25GB.B0016] and the National Cancer Institute at the National Institutes of Health, T32 post-doctoral training fellowship in Cancer Prevention, Etiology and Control at the Johns Hopkins Bloomberg School of Public Health [http://www.cancer.gov/researchandfunding/cancertraining/atnci/programs; 5T32CA009314-28 to MM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Copyright Statement: Authors Eric S. Halsey and Maya Williams are military service members and V. Alberto Laguna-Torres, Stalin Vilcarromero, and Tadeusz J. Kochel are employees of the U.S. Government. This work was prepared as part of their official duties. Title 17 U.S.C. § 105 provides that ‘Copyright protection under this title is not available for any work of the United States Government’. Title 17 U.S.C. § 101 defines a U.S. Government work as a work prepared by military service members or employees of the U.S. Government as part of those persons' official duties.
Authors' addresses: Eric S. Halsey, Maya Williams, V. Alberto Laguna-Torres, and Stalin Vilcarromero, United States Naval Medical Research Unit No. 6, Lima and Iquitos, Peru, E-mails: erichalsey2000@gmail.com, maya.williams@med.navy.mil, alberto.laguna@med.navy.mil, and stalinf@yahoo.com. Victor Ocaña, Dirección Regional de Salud de Piura, Ministerio de Salud, Piura, Peru, E-mail: vocanag01@yahoo.es. Tadeusz J. Kochel, National Biodefense Analysis and Countermeasures Center, Fort Detrick, MD, E-mail: tadeusz.kochel@nbacc.dhs.gov. Morgan A. Marks, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, E-mail: mmarks@jhsph.edu.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI, 2013. The global distribution and burden of dengue. Nature 496: 504–507.
-
2.
World Health Organization (WHO), 2009. Dengue and dengue hemorrhagic fever. Available at: http://www.who.int/mediacentre/factsheets/fs117/en/. Accessed December 1, 2013.
-
3.
Simmons CP, Farrar JJ, Chau NV, Wills B, 2012. Dengue. N Engl J Med 366: 1423–1432.
-
4.
Kularatne SA, 2005. Survey on the management of dengue infection in Sri Lanka: opinions of physicians and pediatricians. Southeast Asian J Trop Med Public Health 36: 1198–1200.
-
5.
Teoh SC, Chee CK, Laude A, Goh KY, Barkham T, Ang BS, 2010. Optical coherence tomography patterns as predictors of visual outcome in dengue-related maculopathy. Retina 30: 390–398.
-
6.
Obeyesekere I, Hermon Y, 1973. Arbovirus heart disease: myocarditis and cardiomyopathy following dengue and chikungunya fever—a follow-up study. Am Heart J 85: 186–194.
-
7.
Solomon T, Dung NM, Vaughn DW, Kneen R, Thao LT, Raengsakulrach B, Loan HT, Day NP, Farrar J, Myint KS, Warrell MJ, James WS, Nisalak A, White NJ, 2000. Neurological manifestations of dengue infection. Lancet 355: 1053–1059.
-
8.
Wang LY, Chang WY, Lu SN, Chen TP, 1990. Sequential changes of serum transaminase and abdominal sonography in patients with suspected dengue fever. Kaohsiung J Med Sci 6: 483–489.
-
9.
Gonzales D, Martinez R, Castro O, Serrano T, Portela D, Vazquez S, Kouri G, Guzman MG, 2005. Evaluation of some clinical, humoral and imagenological parameters in patients of dengue hemorrhagic fever six months after acute illness. Dengue Bull 29: 79–84.
-
10.
Seet RC, Quek AM, Lim EC, 2007. Post-infectious fatigue syndrome in dengue infection. J Clin Virol 38: 1–6.
-
11.
Caballero M, Brown A, Torres E, 1986. Resultado del seguimiento a un grupo de pacientes graves de dengue hemorragico. Rev Cubana Enferm 2: 68–77.
-
12.
del Valle Diaz S, Martinez M, Saent-Felix F, 2001. Hepatitis reactiva por virus del dengue hemorragico. Rev Cubana Med Trop 53: 28–31.
-
13.
Garcia G, Gonzalez N, Perez AB, Sierra B, Aguirre E, Rizo D, Izquierdo A, Sanchez L, Diaz D, Lezcay M, Pacheco B, Hirayama K, Guzman MG, 2011. Long-term persistence of clinical symptoms in dengue-infected persons and its association with immunological disorders. Int J Infect Dis 15: e38–e43.
-
14.
Teixeira L de A, Lopes JS, Martins AG, Campos FA, Miranzi S de S, Nascentes GA, 2010. Persistence of dengue symptoms in patients in Uberaba, Minas Gerais State, Brazil. Cad Saude Publica 26: 624–630.
-
15.
Low JG, Ooi EE, Tolfvenstam T, Leo YS, Hibberd ML, Ng LC, Lai YL, Yap GS, Li CS, Vasudevan SG, Ong A, 2006. Early dengue infection and outcome study (EDEN) - study design and preliminary findings. Ann Acad Med Singapore 35: 783–789.
-
16.
Halsey ES, Marks MA, Gotuzzo E, Fiestas V, Suarez L, Vargas J, Aguayo N, Madrid C, Vimos C, Kochel TJ, Laguna-Torres VA, 2012. Correlation of serotype-specific dengue virus infection with clinical manifestations. PLoS Negl Trop Dis 6: e1638.
-
17.
Forshey BM, Guevara C, Laguna-Torres VA, Cespedes M, Vargas J, Gianella A, Vallejo E, Madrid C, Aguayo N, Gotuzzo E, Suarez V, Morales AM, Beingolea L, Reyes N, Perez J, Negrete M, Rocha C, Morrison AC, Russell KL, Blair PJ, Olson JG, Kochel TJ, 2010. Arboviral etiologies of acute febrile illnesses in Western South America, 2000–2007. PLoS Negl Trop Dis 4: e787.
-
18.
Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV, 1992. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 30: 545–551.
-
19.
Vaughn DW, Nisalak A, Solomon T, Kalayanarooj S, Nguyen MD, Kneen R, Cuzzubbo A, Devine PL, 1999. Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am J Trop Med Hyg 60: 693–698.
-
20.
PAHO. Dengue: statistics and maps. Available at: http://www.paho.org/HQ/index.php?option=com_content&view=article&id=719%3Anumber-of-reported-cases-of-dengue-and-dengue-hemorrhagic-fever-dhf%2A-in-the-americas%2C-by-country&catid=1221%3Ahsd0103b-dengue-statistics-a-maps&Itemid=2481&lang=en. Accessed December 1, 2013.
-
21.
Wilder-Smith A, Schwartz E, 2005. Dengue in travelers. N Engl J Med 353: 924–932.
-
22.
Cobra C, Rigau-Perez JG, Kuno G, Vorndam V, 1995. Symptoms of dengue fever in relation to host immunologic response and virus serotype, Puerto Rico, 1990–1991. Am J Epidemiol 142: 1204–1211.
-
23.
Mickiene A, Laiskonis A, Gunther G, Vene S, Lundkvist A, Lindquist L, 2002. Tickborne encephalitis in an area of high endemicity in Lithuania: disease severity and long-term prognosis. Clin Infect Dis 35: 650–658.
-
24.
Loeb M, Hanna S, Nicolle L, Eyles J, Elliott S, Rathbone M, Drebot M, Neupane B, Fearon M, Mahony J, 2008. Prognosis after West Nile virus infection. Ann Intern Med 149: 232–241.
-
25.
de Andrade DC, Jean S, Clavelou P, Dallel R, Bouhassira D, 2010. Chronic pain associated with the chikungunya fever: long lasting burden of an acute illness. BMC Infect Dis 10: 31.
-
26.
Low JG, Ong A, Tan LK, Chaterji S, Chow A, Lim WY, Lee KW, Chua R, Chua CR, Tan SW, Cheung YB, Hibberd ML, Vasudevan SG, Ng LC, Leo YS, Ooi EE, 2011. The early clinical features of dengue in adults: challenges for early clinical diagnosis. PLoS Negl Trop Dis 5: e1191.
-
27.
Wang CC, Lee IK, Su MC, Lin HI, Huang YC, Liu SF, Wu CC, Lin MC, 2009. Differences in clinical and laboratory characteristics and disease severity between children and adults with dengue virus infection in Taiwan, 2002. Trans R Soc Trop Med Hyg 103: 871–877.
-
28.
Vijayakumar KP, Nair Anish TS, George B, Lawrence T, Muthukkutty SC, Ramachandran R, 2011. Clinical profile of chikungunya patients during the epidemic of 2007 in Kerala, India. J Glob Infect Dis 3: 221–226.
-
29.
Berner YN, Lang R, Chowers MY, 2002. Outcome of West Nile fever in older adults. J Am Geriatr Soc 50: 1844–1846.
-
30.
Fried JR, Gibbons RV, Kalayanarooj S, Thomas SJ, Srikiatkhachorn A, Yoon IK, Jarman RG, Green S, Rothman AL, Cummings DA, 2010. Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl Trop Dis 4: e617.
-
31.
Chan KS, Chang JS, Chang K, Lin CC, Huang JH, Lin WR, Chen TC, Hsieh HC, Lin SH, Lin JC, Lu PL, Chen YH, Lin CY, Tsai JJ, 2009. Effect of serotypes on clinical manifestations of dengue fever in adults. J Microbiol Immunol Infect 42: 471–478.
-
32.
OhAinle M, Balmaseda A, Macalalad AR, Tellez Y, Zody MC, Saborio S, Nunez A, Lennon NJ, Birren BW, Gordon A, Henn MR, Harris E, 2011. Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Sci Transl Med 3: 114–128.
-
33.
Krishnamoorthy K, Harichandrakumar KT, Krishna Kumari A, Das LK, 2009. Burden of chikungunya in India: estimates of disability adjusted life years (DALY) lost in 2006 epidemic. J Vector Borne Dis 46: 26–35.
-
34.
Proll S, Dobler G, Pfeffer M, Jelinek T, Nothdurft HD, Loscher T, 1999. Persistent arthralgias in Ross-River-Virus disease after travel to the South Pacific. Dtsch Med Wochenschr 124: 759–762.
-
35.
Halsey ES, Siles C, Guevara C, Vilcarromero S, Jhonston EJ, Ramal C, Aguilar PV, Ampuero JS, 2013. Mayaro virus infection, Amazon basin region, Peru, 2010–2013. Emerg Infect Dis 19: 1839–1842.
-
36.
Dupuis-Maguiraga L, Noret M, Brun S, Le Grand R, Gras G, Roques P, 2012. Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis 6: e1446.
-
37.
Solomon T, 2004. Flavivirus encephalitis. N Engl J Med 351: 370–378.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1748 | 1522 | 29 |
| Full Text Views | 443 | 14 | 0 |
| PDF Downloads | 168 | 16 | 0 |